AK112 Plus Platinum-based Chemotherapy for EGFR/ALK/ROS1 Positve NSCLC
Condition(s):EfficacyLast Updated:March 12, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):EfficacyLast Updated:March 12, 2024Not yet recruiting
Condition(s):Advanced Lung CancerLast Updated:December 28, 2023Recruiting
Condition(s):Advanced Non-Small Cell Lung CancerLast Updated:December 18, 2023Recruiting
Condition(s):Non Small Cell Lung CancerLast Updated:January 10, 2024Recruiting
Condition(s):Advanced Solid TumorLast Updated:January 9, 2024Recruiting
Condition(s):Advanced Solid Tumors or LymphomasLast Updated:December 11, 2023Recruiting
Condition(s):NSCLCLast Updated:October 6, 2023Completed
Condition(s):NSCLCLast Updated:December 27, 2023Recruiting
Condition(s):NSCLCLast Updated:December 28, 2023Not yet recruiting
Condition(s):Extensive-stage Small-cell Lung CancerLast Updated:December 27, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.